+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction



A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction



American Journal of Obstetrics & Gynecology 180(5): 1155-1160



OBJECTIVE: Our purpose was to compare orally administered with vaginally administered misoprostol for cervical ripening and labor induction. MATERIAL AND METHODS: Two hundred twenty subjects with medical or obstetric indications for labor induction and undilated, uneffaced cervices were randomly assigned to receive orally administered or vaginally administered misoprostol. Fifty micrograms of oral misoprostol or 25 mug of vaginal misoprostol was given every 4 hours. If cervical ripening (Bishop score of gtoreq8 or cervical dilatation of gtoreq3) or active labor did not occur, repeated doses were given to a maximum of 6 doses or 24 hours. Thereafter, oxytocin was administered intravenously by a standardized incremental infusion protocol to a maximum of 22 mU/min. RESULTS: Of the 220 subjects evaluated, 110 received orally administered misoprostol and 110 received vaginally administered misoprostol. Fewer subjects who received the oral preparation (34/110, 30.9%) were delivered vaginally within 24 hours of initiation of induction, in comparison with those who received the vaginal preparation (52/110, 47.3%) (P = .01). The average interval from start of induction to vaginal delivery was nearly 6 hours longer in the oral treatment group (mean and SD 1737.9 +- 845.7 minutes) than in the vaginal treatment group (mean and SD 1393.2 +- 767.9) (P = .005, log-transformed data). Orally treated patients required significantly more doses than vaginally treated patients (orally administered doses: mean and SD 3.3 +- 1.7; vaginally administered doses: mean and SD 2.3 +- 1.2) (P < .0001). Oxytocin administration was necessary in 83 (75.4%) of 110 orally treated subjects and in 65 (59.1%) of 110 vaginally treated subjects (P = .01, relative risk 1.28, 95% confidence interval 1.06-1.54). Vaginal delivery occurred in 95 (86.4%) orally treated subjects and in 85 (77.3%) vaginally treated subjects (P = .08, relative risk 1.12, 95% confidence interval 0.99-1.27), with the remainder undergoing cesarean delivery. There was no difference in the incidence of uterine contractile abnormalities (tachysystole, hypertonus, or hyperstimulation), intrapartum complications, or neonatal outcomes between the 2 groups. CONCLUSIONS: Oral administration of 50-mug doses of misoprostol appears less effective than vaginal administration of 25-mug doses of misoprostol for cervical ripening and labor induction. Further investigation is needed to determine whether orally administered misoprostol should be used for cervical ripening and labor induction.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010055458

Download citation: RISBibTeXText

PMID: 10329871

DOI: 10.1016/s0002-9378(99)70610-1


Related references

Comparison of 25 and 50 mug vaginally administered misoprostol for preinduction of cervical ripening and labor induction. Gynecologic & Obstetric Investigation 53(1): 16-21, 2002

Comparison of 25 and 50 g Vaginally Administered Misoprostol for Preinduction of Cervical Ripening and Labor Induction. Gynecologic and Obstetric Investigation 53(1): 16-21, 2002

Comparison of 25 and 50 microg vaginally administered misoprostol for preinduction of cervical ripening and labor induction. Gynecologic and Obstetric Investigation 53(1): 16-21, 2002

A comparison of vaginally administered misoprostol with extraamniotic saline infusion for cervical ripening and labor induction. American Journal of Obstetrics & Gynecology 185(6 Supplement): S203, 2001

A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction. American Journal Of Obstetrics & Gynecology. 175(1): 158-164, 1996

A comparison of vaginally administered misoprostol with extra-amniotic saline solution infusion for cervical ripening and labor induction. American Journal of Obstetrics & Gynecology 187(4): 847-852, 2002

Vaginally administered misoprostol versus the dinoprostone vaginal insert for preinduction cervical ripening and labor induction. American Journal of Obstetrics & Gynecology 176(1 PART 2): S113, 1997

The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy. Contraception 72(1): 33-39, 2005

A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervical examinations. American Journal of Obstetrics and Gynecology 190(6): 1689-94; Discussion 1694-6, 2004

Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology 185(4): 916-919, 2001

Vaginally administered misoprostol for outpatient labor induction in pregnancies with diabetes mellitus. American Journal of Obstetrics & Gynecology 184(1): S120, 2001

The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management. Bjog 107(9): 1104-1110, 2000

Orally administered misoprostol for induction of labor with prelabor rupture of membranes at term. Journal of Midwifery and Women's Health 59(3): 254-263, 2015

Oral misoprostol vs. vaginal misoprostol for cervical ripening and labor induction. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 89(2): 142-143, 2005

A Randomized Clinical Trial Comparing Vaginal Misoprostol versus Cervical Foley Plus Oral Misoprostol for Cervical Ripening and Labor Induction. Yearbook of Obstetrics, Gynecology and Women's Health 2009: 83-84, 2009